Uncommon Cents Investing LLC decreased its holdings in Plexus Corp. (NASDAQ:PLXS – Free Report) by 3.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,020 shares of the technology company’s stock after selling 375 shares during the quarter. Uncommon Cents Investing LLC’s holdings in Plexus were worth $1,192,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of PLXS. Citigroup Inc. lifted its position in shares of Plexus by 8.3% during the 1st quarter. Citigroup Inc. now owns 24,447 shares of the technology company’s stock valued at $2,000,000 after buying an additional 1,870 shares in the last quarter. Bank of Montreal Can lifted its holdings in Plexus by 7.5% during the first quarter. Bank of Montreal Can now owns 8,488 shares of the technology company’s stock valued at $716,000 after purchasing an additional 592 shares in the last quarter. MetLife Investment Management LLC grew its position in shares of Plexus by 54.1% in the first quarter. MetLife Investment Management LLC now owns 14,788 shares of the technology company’s stock valued at $1,210,000 after purchasing an additional 5,189 shares during the period. Rhumbline Advisers increased its stake in shares of Plexus by 5.4% during the first quarter. Rhumbline Advisers now owns 79,836 shares of the technology company’s stock worth $6,531,000 after purchasing an additional 4,057 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of Plexus by 13.4% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 24,222 shares of the technology company’s stock worth $1,982,000 after purchasing an additional 2,871 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.
Insider Activity
In other news, CEO Todd P. Kelsey sold 2,000 shares of Plexus stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $105.60, for a total transaction of $211,200.00. Following the sale, the chief executive officer now owns 106,900 shares of the company’s stock, valued at approximately $11,288,640. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CEO Todd P. Kelsey sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $105.60, for a total transaction of $211,200.00. Following the completion of the sale, the chief executive officer now directly owns 106,900 shares of the company’s stock, valued at approximately $11,288,640. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michael J. Running sold 542 shares of the business’s stock in a transaction dated Tuesday, January 30th. The shares were sold at an average price of $95.60, for a total transaction of $51,815.20. Following the completion of the sale, the insider now owns 1,569 shares in the company, valued at $149,996.40. The disclosure for this sale can be found here. Insiders sold a total of 34,453 shares of company stock valued at $3,324,075 in the last 90 days. Company insiders own 2.39% of the company’s stock.
Plexus Stock Performance
Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings results on Thursday, January 25th. The technology company reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.01). Plexus had a net margin of 3.08% and a return on equity of 12.16%. The firm had revenue of $982.61 million for the quarter, compared to analyst estimates of $982.57 million. During the same period in the previous year, the firm posted $1.49 EPS. The company’s revenue was down 10.2% compared to the same quarter last year. On average, research analysts predict that Plexus Corp. will post 4.25 EPS for the current year.
Analyst Ratings Changes
Several research firms have commented on PLXS. Benchmark reiterated a “buy” rating and set a $110.00 price objective on shares of Plexus in a research note on Wednesday, January 17th. Sidoti downgraded Plexus from a “buy” rating to a “neutral” rating and set a $112.00 price objective for the company. in a research note on Tuesday, January 9th. TheStreet cut shares of Plexus from a “b” rating to a “c+” rating in a research note on Tuesday, February 13th. Finally, Needham & Company LLC reduced their target price on shares of Plexus from $110.00 to $107.00 and set a “buy” rating for the company in a research report on Thursday, January 25th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $109.67.
Check Out Our Latest Stock Report on Plexus
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
See Also
- Five stocks we like better than Plexus
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Stock Splits, Do They Really Impact Investors?
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.